Covered recipient · General Payments record
DAVID BADAMI
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2023
$451.06
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $411.70 | 25 |
| Education | $8.45 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $158.20 | 10 |
| Lilly USA, LLC | $79.39 | 4 |
| Novo Nordisk AS | $77.87 | 5 |
| Amgen Inc. | $29.84 | 2 |
| PFIZER INC. | $27.74 | 2 |
| Abbott Laboratories | $18.52 | 1 |
| Otsuka America Pharmaceutical, Inc. | $15.69 | 1 |
| GlaxoSmithKline, LLC. | $12.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2023 2022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.52 | 07/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018500899 | CMS |
| AbbVie Inc. | $19.34 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996187023 | CMS |
| AbbVie Inc. | $4.53 | 03/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996187025 | CMS |
| AbbVie Inc. | $23.24 | 04/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996187029 | CMS |
| AbbVie Inc. | $3.17 | 04/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996187031 | CMS |
| AbbVie Inc. | $8.45 | 05/25/2023 | Education | Undisputed | 01/23/2026 | 996187033 | CMS |
| AbbVie Inc. | $4.06 | 05/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996187035 | CMS |
| AbbVie Inc. | $13.46 | 07/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996187037 | CMS |
| AbbVie Inc. | $23.68 | 10/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996187039 | CMS |
| AbbVie Inc. | $31.92 | 12/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996187041 | CMS |
| AbbVie Inc. | $26.35 | 12/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996187043 | CMS |
| Amgen Inc. | $13.75 | 08/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020565111 | CMS |
| Amgen Inc. | $16.09 | 11/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020565113 | CMS |
| GlaxoSmithKline, LLC. | $12.90 | 10/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001538053 | CMS |
| Lilly USA, LLC | $24.71 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031369665 | CMS |
| Lilly USA, LLC | $18.51 | 02/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031369661 | CMS |
| Lilly USA, LLC | $19.11 | 06/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031322271 | CMS |
| Lilly USA, LLC | $17.06 | 07/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031434837 | CMS |
| Novo Nordisk Inc | $15.61 | 01/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002930497 | CMS |
| Novo Nordisk Inc | $15.04 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002930473 | CMS |
| Novo Nordisk Inc | $18.56 | 03/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002930509 | CMS |
| Novo Nordisk Inc | $15.41 | 03/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002930485 | CMS |
| Novo Nordisk Inc | $13.25 | 04/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002930457 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.69 | 12/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014202527 | CMS |
| PFIZER INC. | $13.28 | 05/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049380849 | CMS |
| PFIZER INC. | $14.46 | 08/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050087447 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.